LRCX vs MLAB: fair value comparison
Lam Research Corporation and Mesa Laboratories, Inc. · Updated 2026-10-26
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Technology, MLAB currently sits closer to the top of our ranking by discount to fair value. LRCX carries the stronger quality grade.
| LRCX | MLAB | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $263.94 | $128.66 |
| 12-month range | $139.59–$433.33 | $70.60–$142.23 |
| Rank by discount to fair value | #94 of 182 Technology | #89 of 182 Technology |
| Quality grade | A | B |
| Leverage | Low | Moderate |
| Margin trend | Expanding | Expanding |
| Revenue growth | High | Modest |
| RSI zone | Oversold | Neutral |
| 50/200-day trend | — | Uptrend |
| DCF cross-check | — | Overvalued |
| 52-week position | The lower-middle quarter | The top quarter |
Full single-stock breakdowns: LRCX fair value analysis · MLAB fair value analysis